Royal Bank of Canada »

Telomir Pharmaceuticals shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Telomir Pharmaceuticals (TELO) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Telomir Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Telomir Pharmaceuticals held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Telomir Pharmaceuticals by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.0k 453 4.42

More positions owned by Royal Bank of Canada

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl A (GOOGL)
Bank Of Montreal Cadcom (BMO)
JPMorgan Chase & Co. (JPM)
Bk Nova Cad (BNS)
Enbridge (ENB)
Visa Com Cl A (V)

View all positions for Royal Bank of Canada

Top funds holding Telomir Pharmaceuticals

BlackRock
Geode Capital Management
Bank of New York Mellon
Vanguard Group
Suncoast Equity Management
New York State Common Retirement Fund
State Street Corporation
Beaird Harris Wealth Management
Charles Schwab Investment Management
Citigroup
Morgan Stanley
Rhumbline Advisers
Bank of America Corporation
Jpmorgan Chase & Co
Wells Fargo & Company

View all funds holding Telomir Pharmaceuticals